Fundz

Fundz Deep Dive

Everything you need to win Hikma Pharmaceuticals PLC — in one platform.

Who to reach, what to say, and why now on Hikma Pharmaceuticals PLC — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Hikma Pharmaceuticals PLC — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Hikma Pharmaceuticals and IFC Sign $250 Million Financing Agreement to Enhance Medicine Access in MENA.

Jul 15, 2025•11 months ago

Contract Type

partnership

London

Description

Hikma Pharmaceuticals PLC and the International Finance Corporation have signed a $250 million financing agreement aimed at improving access to medicines in the MENA region. This partnership has a history of 40 years and reinforces IFC's commitment to support Hikma's operations and local production of medicines.

Company Information

Company

Hikma Pharmaceuticals PLC

Location

London, Ontario, Canada

About

Hikma helps put better health within reach every day for millions of people around the world. For more than 45 years, they've been creating high-quality medicines and making them accessible. Headquartered in the UK, Hikma has a global presence and focuses on transforming cutting-edge science into innovative solutions. Their range includes both branded and non-branded generic medicines.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Hikma Pharmaceuticals PLC's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.